A guide to selecting high-performing antibodies for RNA-binding protein TIA1 for use in Western Blot, immunoprecipitation and immunofluorescence
F1000Research · 08.04.2024 · 12 · 745
DOI: 10.12688/f1000research.133645.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 08.04.2024. Verfasst von Maryam Fotouhi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: RNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ontario Genomics Institute, Boehringer Ingelheim, Takeda.
Abstract (Originalsprache)
A member of the RNA-binding protein family, T-cell intracellular antigen-1 (TIA1) regulates mRNA translation and splicing as well as cellular stress by promoting stress granule formation. Variants of the TIA1 gene have implications in neurogenerative disorders including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Reproducible research on TIA1 would be enhanced with the availability of high-quality anti-TIA1 antibodies. In this study, we characterized twelve TIA1 commercial antibodies for Western Blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
ORCID-Profile: Donovan Worrall, Kathleen Southern, Carl Laflamme
Förderung
- Ontario Genomics Institute
- Boehringer Ingelheim
- Takeda
- ALS Association
- Canadian Institutes of Health Research Foundation
- Pfizer
- Genentech
- EUbOPEN
Zitieren
APA
Fotouhi, M., Worrall, D., Ayoubi, R., Southern, K., McPherson, P. S., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF Consortium (2024). A guide to selecting high-performing antibodies for RNA-binding protein TIA1 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research, 12, 745. https://doi.org/10.12688/f1000research.133645.2
Vancouver
Fotouhi M, Worrall D, Ayoubi R, Southern K, McPherson PS, Laflamme C, et al. A guide to selecting high-performing antibodies for RNA-binding protein TIA1 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. 2024;12:745. doi:10.12688/f1000research.133645.2
BibTeX
@article{Fotouhi2024,
author = {Fotouhi, Maryam and Worrall, Donovan and Ayoubi, Riham and Southern, Kathleen and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF Consortium, ABIF Consortium},
title = {A guide to selecting high-performing antibodies for RNA-binding protein TIA1 for use in Western Blot, immunoprecipitation and immunofluorescence},
journal = {F1000Research},
year = {2024},
volume = {12},
pages = {745},
doi = {10.12688/f1000research.133645.2}
}
EUVIMED